BACKGROUND: Clinical and experimental studies have traditionally focused on understanding the mechanisms for why a heart fails. We hypothesize that the pathways involved with myocardial recovery are not simply the reverse of those that cause heart failure. However, determining when and how a decompensated heart can recover remains unknown. METHODS: Male C57BL/6 mice underwent minimally invasive aortic banding for 3, 4, or 6 wk with or without subsequent band removal for 1 wk (debanding). Physiologic and genomic characterization was performed with intracardiac pressure-volume recordings, rt-PCR, and microarray analysis. RESULTS: Heart weight/body weight ratios and PV loops demonstrated a transition from compensated left ventricular hypertrophy to decompensated heart failure between 3 and 4 wk. Pressure-relief afforded by debanding allowed functional recovery and normalization of LVH after both 3 and 4, but not 6 wk of banding. Whole genome microarrays demonstrated 397 genes differentially expressed in recovered hearts, 250 genes differentially expressed in the nonrecoverable (6 wk) hearts, and only 10 genes shared by both processes. In particular, altered expression patterns of apoptotic and metalloproteinase genes correlated with the heart's ability to functionally recover. CONCLUSIONS: This clinically-relevant model (1) allows us to temporally and mechanistically characterize the failing heart, (2) demonstrates a unique genomic signature that may predict when a failing heart can recover following pressure relief, and (3) will prove useful as a template for testing therapeutic strategies aimed at recovery of the failing heart.
BACKGROUND: Clinical and experimental studies have traditionally focused on understanding the mechanisms for why a heart fails. We hypothesize that the pathways involved with myocardial recovery are not simply the reverse of those that cause heart failure. However, determining when and how a decompensated heart can recover remains unknown. METHODS: Male C57BL/6 mice underwent minimally invasive aortic banding for 3, 4, or 6 wk with or without subsequent band removal for 1 wk (debanding). Physiologic and genomic characterization was performed with intracardiac pressure-volume recordings, rt-PCR, and microarray analysis. RESULTS: Heart weight/body weight ratios and PV loops demonstrated a transition from compensated left ventricular hypertrophy to decompensated heart failure between 3 and 4 wk. Pressure-relief afforded by debanding allowed functional recovery and normalization of LVH after both 3 and 4, but not 6 wk of banding. Whole genome microarrays demonstrated 397 genes differentially expressed in recovered hearts, 250 genes differentially expressed in the nonrecoverable (6 wk) hearts, and only 10 genes shared by both processes. In particular, altered expression patterns of apoptotic and metalloproteinase genes correlated with the heart's ability to functionally recover. CONCLUSIONS: This clinically-relevant model (1) allows us to temporally and mechanistically characterize the failing heart, (2) demonstrates a unique genomic signature that may predict when a failing heart can recover following pressure relief, and (3) will prove useful as a template for testing therapeutic strategies aimed at recovery of the failing heart.
Authors: Gavin R Norton; Angela J Woodiwiss; William H Gaasch; Theofanie Mela; Eugene S Chung; Gerard P Aurigemma; Theo E Meyer Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: Donald M Lloyd-Jones; Martin G Larson; Eric P Leip; Alexa Beiser; Ralph B D'Agostino; William B Kannel; Joanne M Murabito; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy Journal: Circulation Date: 2002-12-10 Impact factor: 29.690
Authors: Florian Grabellus; Bodo Levkau; Andrea Sokoll; Hendryk Welp; Christof Schmid; Mario C Deng; Atsushi Takeda; Günter Breithardt; Hideo A Baba Journal: Cardiovasc Res Date: 2002-01 Impact factor: 10.787
Authors: Stavros G Drakos; Abdallah G Kfoury; Elizabeth H Hammond; Bruce B Reid; Monica P Revelo; Brad Y Rasmusson; Kevin J Whitehead; Mohamed E Salama; Craig H Selzman; Josef Stehlik; Stephen E Clayson; Michael R Bristow; Dale G Renlund; Dean Y Li Journal: J Am Coll Cardiol Date: 2010-07-27 Impact factor: 24.094
Authors: Natalia Novoradovskaya; Michael L Whitfield; Lee S Basehore; Alexey Novoradovsky; Robert Pesich; Jerry Usary; Mehmet Karaca; Winston K Wong; Olga Aprelikova; Michael Fero; Charles M Perou; David Botstein; Jeff Braman Journal: BMC Genomics Date: 2004-03-09 Impact factor: 3.969
Authors: Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck Journal: Cardiovasc Res Date: 2016-03-10 Impact factor: 10.787
Authors: Deanna L Muehleman; Claudia Crocini; Alison R Swearingen; Christopher D Ozeroff; Leslie A Leinwand Journal: Am J Physiol Heart Circ Physiol Date: 2022-03-18 Impact factor: 4.733
Authors: Carla J Weinheimer; Attila Kovacs; Sarah Evans; Scot J Matkovich; Philip M Barger; Douglas L Mann Journal: Circ Heart Fail Date: 2018-05 Impact factor: 8.790
Authors: Cinzia Perrino; Albert-Laszló Barabási; Gianluigi Condorelli; Sean Michael Davidson; Leon De Windt; Stefanie Dimmeler; Felix Benedikt Engel; Derek John Hausenloy; Joseph Addison Hill; Linda Wilhelmina Van Laake; Sandrine Lecour; Jonathan Leor; Rosalinda Madonna; Manuel Mayr; Fabrice Prunier; Joost Petrus Geradus Sluijter; Rainer Schulz; Thomas Thum; Kirsti Ytrehus; Péter Ferdinandy Journal: Cardiovasc Res Date: 2017-06-01 Impact factor: 10.787